109 related articles for article (PubMed ID: 18327983)
1. Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.
Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Deforche K; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; van den Heuvel A; van der Gucht B; van Ranst M; van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Vandamme AM; van Laethem K
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):355-62. PubMed ID: 18327983
[TBL] [Abstract][Full Text] [Related]
2. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
4. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
Van Vaerenbergh K; Debaisieux L; De Cabooter N; Declercq C; Desmet K; Fransen K; Maes B; Marissens D; Miller K; Muyldermans G; Sprecher S; Stuyver L; Vaira D; Verhofstede C; Zissis G; Van Ranst M; De Clercq E; Desmyter J; Vandamme AM
Antivir Ther; 2001 Mar; 6(1):63-70. PubMed ID: 11417763
[TBL] [Abstract][Full Text] [Related]
6. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger.
Charpentier C; Bellecave P; Cisse M; Mamadou S; Diakite M; Peytavin G; Tchiombiano S; Teisseire P; Pizarro L; Storto A; Brun-Vézinet F; Katlama C; Calvez V; Marcelin AG; Masquelier B; Descamps D
Antivir Ther; 2011; 16(3):429-33. PubMed ID: 21555827
[TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
10. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
11. Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.
Park SW; Kim HB; Choi YJ; Kim NJ; Oh MD; Choe KW
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):1039-43. PubMed ID: 14686324
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
[TBL] [Abstract][Full Text] [Related]
13. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
[TBL] [Abstract][Full Text] [Related]
15. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
[TBL] [Abstract][Full Text] [Related]
16. Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE.
Maljkovic I; Wilbe K; Sölver E; Alaeus A; Leitner T
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):989-97. PubMed ID: 14678606
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
[TBL] [Abstract][Full Text] [Related]
18. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil.
Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA
J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
Arora SK; Gupta S; Toor JS; Singla A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
